PathoQuest is a molecular diagnostics company that offers an approach to improving pathogen detection in biological samples. Its technology combines a next-generation sequencing (NGS) platform and a sample preparation process which is applicable to several types of samples with a pathogen genome sequence database and automated analysis pipeline. Besides, the company develops iDTECT Blood, a CE IVD metagenomic test for clinical infectious disease diagnosis. Based on its technological platform, the company also provides biopharmaceutical companies with biological genomic services.
|Employees (est.) (Oct 2019)||26|
PathoQuest total Funding
PathoQuest latest funding size
Time since last funding
|a month ago|
|Idinvest Partners, Aurinvest, Kurma Partners, investiere | Verve Capital Partners, Fraser Finance, Norgine Ventures, Charles River Labs|
PathoQuest has 89 Twitter Followers. The number of followers has increased 1.3% month over month and increased 1.3% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
Who are PathoQuest key executives?
PathoQuest's key executives are Jean-Francois Brepson, Stéphane Cruveiller and Violaine Mélen.
How many employees does PathoQuest have?
PathoQuest has 26 employees.
Who are PathoQuest competitors?
Competitors of PathoQuest include Mammoth Biosciences, Ontera and Bioarray Therapeutics.
Where is PathoQuest headquarters?
PathoQuest headquarters is located at Jardin Biopark, 11 Rue Watt, Paris.
Where are PathoQuest offices?
PathoQuest has an office in Paris.
How many offices does PathoQuest have?
PathoQuest has 1 office.
Receive alerts for 300+ data fields across thousands of companies